96 related articles for article (PubMed ID: 2501690)
1. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate].
van der Zwan A
Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690
[TBL] [Abstract][Full Text] [Related]
2. [Parkinsonism due to the medication].
Louter M; Tromp SC
Ned Tijdschr Geneeskd; 2009; 153():A336. PubMed ID: 19900308
[TBL] [Abstract][Full Text] [Related]
3. [Valproate induced parkinsonism].
Park-Matsumoto YC; Tazawa T
No To Shinkei; 1998 Jan; 50(1):81-4. PubMed ID: 9493204
[TBL] [Abstract][Full Text] [Related]
4. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
Ristić AJ; Vojvodić N; Janković S; Sindelić A; Sokić D
Epilepsia; 2006 Dec; 47(12):2183-5. PubMed ID: 17201721
[TBL] [Abstract][Full Text] [Related]
5. [Parkinsonism induced by sodium valproate].
del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
[TBL] [Abstract][Full Text] [Related]
6. Parkinsonian syndrome in childhood after sodium valproate administration.
Alvarez-Gomez MJ; Vaamonde J; Narbona J; Barao M; Barona P; Brannan T; Gudin M; Ibañez R
Clin Neuropharmacol; 1993 Oct; 16(5):451-5. PubMed ID: 8221706
[TBL] [Abstract][Full Text] [Related]
7. Reversible dementia and apparent brain atrophy during valproate therapy.
Papazian O; Cañizales E; Alfonso I; Archila R; Duchowny M; Aicardi J
Ann Neurol; 1995 Oct; 38(4):687-91. PubMed ID: 7574471
[TBL] [Abstract][Full Text] [Related]
8. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
Hayashi T; Yoshida S; Yoshinaga A; Ohno R; Ishii N; Yamada T
Scand J Urol Nephrol; 2005; 39(5):431-2. PubMed ID: 16257847
[TBL] [Abstract][Full Text] [Related]
9. [Dementia and extrapyramidal problems caused by long-term valproic acid].
Masmoudi K; Gras-Champel V; Bonnet I; Pannier M; Masson H; Rosa A; Andréjak M
Therapie; 2000; 55(5):629-34. PubMed ID: 11201978
[TBL] [Abstract][Full Text] [Related]
10. [Cognitive impairment and parkinsonism due to use of sodium valproate].
Schreur L; Middeljans-Tijssen CW; Hengstman GJ; Olde Rikkert MG
Tijdschr Gerontol Geriatr; 2009 Feb; 40(1):29-33. PubMed ID: 19326700
[TBL] [Abstract][Full Text] [Related]
11. [A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder].
Ricard C; Martin K; Tournier M; Bégaud B; Verdoux H
Encephale; 2005; 31(1 Pt 1):98-101. PubMed ID: 15971646
[TBL] [Abstract][Full Text] [Related]
12. Seizure control and side-effect profile after switching adult epileptic patients from standard to extended-release divalproex sodium.
Pierre-Louis SJ; Brannegan RT; Evans AT
Clin Neurol Neurosurg; 2009 Jun; 111(5):437-41. PubMed ID: 19181439
[TBL] [Abstract][Full Text] [Related]
13. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
[TBL] [Abstract][Full Text] [Related]
14. [Hyperammonemia during sodium valproate therapy: clinically relevant or accidental finding?].
Ettlin T; Scollo-Lavizzari G
Schweiz Rundsch Med Prax; 1986 Jul; 75(29):881-5. PubMed ID: 3090672
[No Abstract] [Full Text] [Related]
15. [Tremor in the course of sodium valproate treatment].
Dugas M; Brunod R; Masson M
Nouv Presse Med; 1981 Sep; 10(34):2828. PubMed ID: 6796937
[No Abstract] [Full Text] [Related]
16. Acetazolamide appears effective in the management of valproate-induced tremor.
Lancman ME; Asconapé JJ; Walker F
Mov Disord; 1994 May; 9(3):369. PubMed ID: 8041383
[No Abstract] [Full Text] [Related]
17. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
18. Successful initiation of combined therapy with valproate sodium injection and divalproex sodium extended-release tablets in the epilepsy monitoring unit.
Boggs JG; Preis K
Epilepsia; 2005 Jun; 46(6):949-51. PubMed ID: 15946337
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
Klotz U; Schweizer C
Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
[TBL] [Abstract][Full Text] [Related]
20. Chrono impact versus enteric coated valproate in Thai epileptic patients.
Towanabut S; Tiemkao S; Thammasupapong S; Kijjarak R; Arayawichanon A; Poungvarin N; Sirimaharaj S; Chaisewikul R; Asawavichenjinda T; Maneesuk S; Silpakit O
J Med Assoc Thai; 2005 Nov; 88(11):1651-9. PubMed ID: 16471115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
